Literature DB >> 3831718

Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice.

S Takai, T Michizoe, K Matsumura, M Nagai, H Sato, S Tsubaki.   

Abstract

To study the virulence of Rhodococcus (Corynebacterium) equi, seven ATCC strains of different serotypes were tested for their LD50 in mice, clearance of the organism from the lungs and spleen following intravenous or intratracheal inoculation, and in vitro interaction with murine peritoneal macrophages. Strains ATCC 33704 and 33705 were virulent for mice and multiplied in the lungs and spleen, resulting in death of the animal in 5 days. The other five strains were avirulent for mice. The number of bacteria in the lungs and spleen of mice given these five strains decreased immediately. Pulmonary clearance of strains ATCC 33703, 33706, and 33707 was significantly more rapid than that of the virulent strains ATCC 33704 and 33705 12 hr after inoculation. Complete clearance of the avirulent strain ATCC 33707 occurred by day 14, while that of virulent ATCC 33704 and 33705 strains occurred by day 30. The virulent strains ATCC 33704 and 33705 were resistant not only to phagocytosis but also to intracellular killing by macrophages. Strains ATCC 33702 and 33706 were rapidly killed by macrophages although they were rather resistant to phagocytosis. Strain ATCC 33703 was easily phagocytized though resistant to killing by macrophages. The most avirulent strains, ATCC 33707 and 6939, were easily phagocytized and rapidly killed by macrophages. These results indicate that virulence appeared to be related to the ability of the organisms to resist clearance from the lungs and spleen and to resist phagocytosis and intracellular killing by macrophages.

Entities:  

Mesh:

Year:  1985        PMID: 3831718     DOI: 10.1111/j.1348-0421.1985.tb00907.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  16 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi.

Authors:  S Takai; K Koike; S Ohbushi; C Izumi; S Tsubaki
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  VapA of Rhodococcus equi binds phosphatidic acid.

Authors:  Lindsay M Wright; Emily M Carpinone; Terry L Bennett; Mary K Hondalus; Vincent J Starai
Journal:  Mol Microbiol       Date:  2017-12-22       Impact factor: 3.501

4.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Role of T-lymphocyte subsets in Rhodococcus equi infection.

Authors:  P Nordmann; E Ronco; C Nauciel
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi.

Authors:  S Takai; T Sekizaki; T Ozawa; T Sugawara; Y Watanabe; S Tsubaki
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.

Authors:  Andrea K Kohler; Diana M Stone; Melissa T Hines; Barbara A Byrne; Debra C Alperin; Linda K Norton; Stephen A Hines
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates.

Authors:  P Nordmann; M Keller; F Espinasse; E Ronco
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Rhodococcus equi plasmids: isolation and partial characterization.

Authors:  O Tkachuk-Saad; J Prescott
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 10.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.